VMD-928
NCT03556228
VM Oncology · Phase 1/2 · Recruiting · Enrollment 242
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
VMD-928
VM Oncology · Phase 1/2 · Recruiting · Enrollment 242
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.